Cite
MLA Citation
Scott Schobel et al.. “J02 A global development program testing RG6042, an anti-sense oligonucleotide, for the treatment of early manifest huntington's disease (hd).” Journal of neurology, neurosurgery and psychiatry, vol. 89, n.d., p. A98. http://access.bl.uk/ark:/81055/vdc_100135156875.0x000035